Don't all Canadian Microcap Biotechs go backwards after gaining entry into to the Chinese market for one of it's products?
I realize that this treatment might seem insignificant in and of itself, BUT the distribution partner is rather interesting given that BNC has dozens of other products on its Animal Health shelves that do not yet have Chinese distribution in place.
Had this Chinese partner stepped up and taken the Immunocidin product into Hong Kong I think we would definitely see the teens today.
Thankfully, this agreement is only for a single Bioniche product at this point in time.
We can only take so much bad news in tax loss season!